Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06156228 · ClinicalTrials.gov registry record · NA
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
A NA study, sponsored by San Diego State University.
- Terminated
- Registry status
- NA
- Development phase
- 238
- Enrollment target
NCT06156228: Clinical Trial NA study, sponsored by San Diego State University.
NCT06156228 is a NA study that was terminated before completion, run by San Diego State University. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06156228, a NA study, was terminated before completion, sponsored by San Diego State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
Study Summary
This study is significant as it targets a population that has exceptionally high rates of morbidity and mortality due to COVID-19, influenza, pneumococcal pneumonia and shingles; and who demonstrate significant mistrust towards the vaccines. It is innovative in that investigators will harness the research team's extensive experience in developing multi-level and tailored interventions working with community partners to increase adult vaccine uptake among Latinos. Through this project the investigators will develop the experience and infrastructure for a scalable community-academic model that can be deployed and adapted to other communities (especially those with prevalent vaccine resistance) and other emerging public health threats. There is great potential for short- and long-term public health/economic impact in increasing adult vaccine uptake among high risk populations such as Latinos. This work will contribute to the body of evidence for effective behavioral- and community-based strategies to improve the health of Latinos.
Primary Outcome
Test Multilevel Intervention effectiveness at baseline, 6-months \& 12-months on Latino patient's vaccine uptake for COVID-19, Pneumococcal, Shingles and Influenza vs. Latino patients receiving Standard Clinical Practice.
Interventions
- BEHAVIORAL Multilevel Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2024-03-06 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Why NCT06156228 stopped before completion
NCT06156228 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Multilevel Intervention is the first listed.
NCT06156228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06156228 about?
NCT06156228 is a clinical study titled "Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos". This study is significant as it targets a population that has exceptionally high rates of morbidity and mortality due to COVID-19, influenza, pneumococcal pneumonia and shingles; and who demonstrate significant mistrust towards the vaccines. It is innovative in that investigators will harness the re...
What is the current status of trial NCT06156228?
This trial is currently terminated. It is a NA study. The enrollment target is 238 participants. The study started on 2024-03-06. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06156228?
The interventions under investigation include: Multilevel Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06156228?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06156228's enrollment target sits among peer trials
238 459th of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI